NCT03275961

Brief Summary

The investigators are doing this research study to find out if the Stress Management and Resiliency Training (SMART) therapy will help subjects with their major depression treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable depression

Timeline
Completed

Started Nov 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 29, 2016

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 6, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 8, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2018

Completed
Last Updated

November 14, 2018

Status Verified

November 1, 2018

Enrollment Period

1.6 years

First QC Date

September 6, 2017

Last Update Submit

November 13, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Connor-Davidson Resilience Scale Score

    The Connor-Davidson Resilience Scale (CD-RISC), a 25-item scale, was developed to measure resiliency. CD-RISC has been evaluated and has been found to have good internal consistency (α = .89), test-retest reliability (intraclass correlation coefficient = .87), and positive correlation with multiple related measures with ability to distinguish between participants with lesser and greater resilience. The scores can range from 0 to 100. The mean score in a general population sample was 80.7 and in psychiatric outpatients 68. A positive change with increasing scores will indicate improvement in resilience.

    baseline, 8 weeks

Secondary Outcomes (5)

  • Change in Hamilton Rating Scale for Depression Score

    baseline, 8 weeks

  • Change in Patient Health Questionnaire-9 Score

    baseline, 8 weeks

  • Change in Quick Inventory of Depressive Symptoms Score

    baseline, 8 weeks

  • Change in Generalized Anxiety Disorder-7 Score

    baseline, 8 weeks

  • Change in Perceived Stress Scale Score

    baseline, 8 weeks

Study Arms (1)

Depressed Subjects

EXPERIMENTAL

Subjects will undergo an 8 week behavioral program with Stress Management and Resiliency Training.

Behavioral: Stress Management and Resiliency Training

Interventions

Subjects will undergo an 8 week behavioral program. Treatment will consist of weekly group therapy sessions in small groups with core practices to apply the principles of SMART.

Also known as: SMART
Depressed Subjects

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Attending the Mayo Clinic Depression Center and Behavioral Health Clinic at Mayo Clinic Health System, Austin, Minnesota
  • DSM-V diagnostic confirmation of major depressive disorder (MDD)
  • Baseline PHQ-9 scores in the range of ≥6-≤19, and HAMD-17 score 8-18, or QIDS-C16 score of 6-20
  • Able to speak English
  • Participants will continue taking any prescribed medications from their clinical treatment team
  • Patients with co-morbid secondary diagnoses of persistent depressive disorder and generalized anxiety disorders will be included in the study.

You may not qualify if:

  • Participants with bipolar disorder
  • Active psychosis
  • Active suicidal ideations
  • Active substance abuse meeting criteria for substance use disorders except nicotine
  • Obsessive compulsive disorder
  • Active Panic disorder with agoraphobia, other phobic disorder
  • Active Posttraumatic stress disorder
  • Active Severe personality disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

Related Publications (1)

  • Seshadri A, Clark MM, Kung S, Fuller-Tyszkiewicz M, Sood A, Dammen KC, Rico JA, Tye SJ, McGillivray J, Frye MA. Feasibility Study of Stress Management and Resiliency Training (SMART) in Patients With Major Depressive Disorder. Prim Care Companion CNS Disord. 2020 Apr 30;22(3):19m02556. doi: 10.4088/PCC.19m02556.

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Ashok Seshadri, M.D.

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant, Instructor in Psychiatry

Study Record Dates

First Submitted

September 6, 2017

First Posted

September 8, 2017

Study Start

November 29, 2016

Primary Completion

July 1, 2018

Study Completion

October 15, 2018

Last Updated

November 14, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share

Locations